Sun Pharmaceutical
SUNPHARMA.NS
#484
Rank
โ‚น4.331 T
Marketcap
โ‚น1,805
Share price
-0.73%
Change (1 day)
1.19%
Change (1 year)

Revenue for Sun Pharmaceutical (SUNPHARMA.NS)

Revenue in 2025 (TTM): โ‚น533.02 Billion

According to Sun Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น562.16 Billion. In 2024 the company made a revenue of โ‚น510.39 Billion an increase over the revenue in the year 2023 that were of โ‚น466.70 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sun Pharmaceutical from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น533.02 B4.44%
2024 โ‚น510.39 B9.36%
2023 โ‚น466.70 B11.28%
2022 โ‚น419.39 B11.92%
2021 โ‚น374.71 B14.08%
2020 โ‚น328.47 B4.97%
2019 โ‚น312.91 B10.36%
2018 โ‚น283.53 B8.3%
2017 โ‚น261.80 B-15.15%
2016 โ‚น308.55 B16.12%
2015 โ‚น265.72 B5.35%
2014 โ‚น252.21 B67.72%
2013 โ‚น150.37 B43.31%
2012 โ‚น104.93 B